Addiction, Health, Behaviour Change | CGL

How we’re helping to improve Hepatitis C screening

How we’re helping to improve Hepatitis C screening

28 March 2019

We are collaborating with Gilead Sciences and the NHS to help increase the number of people accessing screening for Hepatitis C. We have appointed dedicated Hepatitis C Coordinators, who work with services to identify the service users most at risk of infection or who already have a Hepatitis C positive diagnosis.

By using a method of detection known as ‘Dried Blood Spot Testing’, we can identify service users who have Hepatitis C and work with specialist NHS services to provide treatment. By identifying those most at risk of contracting the blood borne virus, we are spreading the message that Hepatitis C is preventable and treatable with little or no side effects.

This collaboration has led to a 36% increase in testing, a doubling of referrals, and three times the number of people being treated since the partnership was introduced. Currently, more than three-quarters of our services have onsite clinics where service users at risk can be tested for Hepatitis C.

We are very pleased to announce that our collaboration with Gilead Sciences and the NHS recently won ‘Best Pharmaceutical Partnership’ at the Health Service Journal Partnership Awards!

Stacey Smith, our Director of Nursing and Clinical Practice said:

 “We are delighted to have won the HSJ Partnership Award in recognition of our work with Gilead Sciences. This innovative partnership has really accelerated Change Grow Live's drive for increased access to Hepatitis C screening and simpler referral pathways in all our service centres nationwide. Together with Gilead, we will strive towards the elimination of Hepatitis C so that more of the people we support can live healthy, full and happy lives.”

Hilary Hutton-Squire, General Manager UK and Ireland at Gilead Sciences added: 

“This award recognizes all of the hard work to date and the strides we are making with our partners in ensuring more patients with Hepatitis C are being diagnosed and cured of this life-threatening disease. I’m proud of what the teams have achieved. Only by working in such partnerships can we make the elimination of Hepatitis C a reality.”